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Abstract In this article, the benefits offered by micro-
fibrous scaffold architectures fabricated by textile manu-
facturing techniques are discussed: How can established
and novel fiber-processing techniques be exploited in order
to generate templates matching the demands of the target
cell niche? The problems related to the development of
biomaterial fibers (especially from nature-derived materi-
als) ready for textile manufacturing are addressed. Atten-
tion is also paid on how biological cues may be
incorporated into micro-fibrous scaffold architectures by
hybrid manufacturing approaches (e.g. nanofiber or
hydrogel functionalization). After a critical review of
exemplary recent research works on cell-free fiber based
scaffolds for in situ TE, including clinical studies, we
conclude that in order to make use of the whole range of
favors which may be provided by engineered fibrous
scaffold systems, there are four main issues which need to
be addressed: (1) Logical combination of manufacturing
techniques and materials. (2) Biomaterial fiber develop-
ment. (3) Adaption of textile manufacturing techniques to
the demands of scaffolds for regenerative medicine. (4)
Incorporation of biological cues (e.g. stem cell homing
factors).
1 Introduction
The classical tissue engineering (TE) approach (in vitro
expansion of cells seeded on scaffolds and subsequent
implantation) has been facing various critical obstacles
concerning the translation to the bedside, namely seeding-
time, laborious effort and cost [1–3]. Hence, in recent years
in situ TE has gained increasing attention [4–8]. In this
more straight-forward approach, the body’s own biologic
resources and reparative capability are utilized by
implanting a cell-free engineered biomaterial (scaffold)
into the site of injury, where host stem cells or tissue
specific progenitor cells are recruited [2]. In situ TE
approaches have been investigated for various possible
applications such as vascular grafts [9], nerve [10] and hard
tissue regeneration [11].
In recent years the general understanding of the require-
ments imposed on scaffolds for TE applications has changed
towards templates which replicate the target cell niche in
terms of their structural architecture and which are capable of
adapting to a changing microenvironment, thus providing
optimal conditions for tissue-ingrowth, nutrient, gas and
biomolecule transport and vascularization [12, 13]. The
scaffold architecture should be dictated by the requirements of
the target cell niche (Fig. 1). To generate scaffolds with
properties tailored to the targeted application, numerous
manufacturingmethods have been employed. Those comprise
solvent casting [14–16], gas foaming [17–19], phase separa-
tion [20, 21], emulsion freeze drying [22–24], additive man-
ufacturing (AM) techniques [25–27], electrospinning [28, 29]
and other fiber formation techniques [30, 31].
The versatility of textile technology allows for the fabri-
cation of 3D spatial structures with tunable properties in the
micro- and macro range [32, 33]. In the past decades, textile
manufacturing techniques have been used in a wide range of
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engineering applications such as fiber reinforced composites
[33], construction textiles [34], filtration [35], medical tex-
tiles [36] etc. Fiber based techniques including electrospin-
ning have been successfully used for the manufacturing of
3D cell laden scaffolds for classical in vitro and in vivo TE
approaches, which are reviewed elsewhere [28, 30]. Through
suitable combinations of material, fiber type and manufac-
turing technique, fiber-based scaffolds can be engineered to
obtain properties similar to native tissue and tomatch critical
scaffold criteria [37]. The mechanical properties can be
adjusted according to the desired properties of native tissue
[38–40]. Besides close structural resemblance of the scaffold
to native host tissue, the success of in situ TE approaches
strongly relies on the scaffolds capability to recruit host stem
cells or tissue specific progenitor cells [2]. Therefore,
information-rich scaffolding systems with incorporated
‘‘cell homing’’ or ‘‘recruiting’’ factors are needed [7, 41].
Nanofiber based scaffolds have been reviewed in detail
elsewhere [42, 43]. Hence, in this review nanofibers are
considered in terms of a major technique for scaffold func-
tionalization and not as structure defining component.
In this article, the benefits offered by micro-fibrous
scaffold architectures fabricated by textile manufacturing
techniques are discussed:
How can established and novel fiber-processing tech-
niques be exploited in order to generate templates
matching the demands of the target cell niche?
Which are the problems related to the development of
biomaterial fibers ready for textile manufacturing?
How may biological cues be incorporated into micro-
fibrous scaffold architectures?
After a critical review of exemplarily selected recent
studies on cell-free fiber based scaffolds for in situ TE,
including clinical trials, the findings of this article are
concluded in order assess the potential and limitations of
cell-free fiber based scaffolds.
2 Benefits of engineered fibrous scaffold
architectures
Textile technology offers various manufacturing methods
to fabricate scaffolds with tailored properties. For cen-
turies, textile manufacturing techniques have been used in
the traditional branches of textile industry [44]. Detailed
descriptions of the principles of knitting, weaving,
braiding and non-woven fabrication as well as their
respective characteristics are given elsewhere [32, 33,
45]. This section describes the favors principally given by
fiber and textile technology to design scaffolds with
adjustable properties matching the target cell niche
(Fig. 2). At the same time, limitations and shortcomings
of the current state of the art in fibrous scaffold engi-
neering are discussed.
Fig. 1 Scaffold development
approach based on the
requirement of the target cell
niche
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2.1 Textiles: three-dimensional spatial structures
with hierarchical porous properties
There are two major groups of fibrous scaffolds for TE and
in situ TE applications: Electrospun nanofibrous meshes
and microfibrous textiles. Nanofibrous scaffolds have
gained increasing attention in the past decade [42]. They
are popular due to their high surface- to volume ration, the
beneficial scale-dimensions for cell adhesion and the
diversity of biomaterials which may be processed [28].
However, nanofibrous scaffolds are restricted to flat, ‘‘two-
dimensional’’ pads, tubed membranes or mechanically
instable spatial structures in the most cases [42]. The
benefit of fibrous engineered architectures which is most
often exploited is their reinforcing function [52, 53]. The
mechanical properties are identified as a crucial factor for
TE scaffolds [49, 54], remarkable coherences between
mechanical stability and cell attachment were found [55,
56].
Engineered fibrous constructs are mostly incorporated
into scaffolds as either flat textile fabrics or tubular struc-
tures made by rolling of flat fabrics or directly produced by
braiding or knitting techniques. An issue which is less
addressed in studies using engineered fibrous scaffolds is
the call for scaffolds with defined pore size and porosity
and with 3D shapes which match specific anatomies. To
match these requirements, additive manufacturing (AM)
techniques have gained increasing attention [25, 57]. The
benefits of AM techniques in scaffold manufacturing are
underlined in various studies [25, 57]. Besides this, textile
manufacturing methods may also be employed for the
fabrication of mechanically stable, three-dimensional spa-
tial structures with hierarchical porous properties. With the
available conventional manufacturing methods (e.g. flat-
knitting, 3D weaving, braiding), net-shaped geometries
may be realized [33]. The pore structure of textile fabrics
can be adjusted by varying the manufacturing parameters
[58]. To learn why there are only little studies using
complexly custom-shaped fibrous scaffolds one has to look
at the manufacturing methods and the research fields that
must be involved.
One main impediment is that industrial textile machines
commonly are in scale dimensions that are inappropriate
for the fabrication of scaffolds. Furthermore, textile man-
ufacturing of complex 3D-structures requires expert
knowledge from textile engineering professionals. There
are several examples in which stronger interdisciplinary
collaboration could have helped to improve the architecture
of the fibrous scaffolds [48, 59–61], thus further improving
the positive results. In order to being able to exploit the
whole bandwidth of benefits offered by engineered fibrous
scaffolds, the technique which suits best for the desired
application needs to be identified among the variety of
available techniques. For instance, circular knitting could
be considered for the fabrication of tubular samples rather
than wrapping and suturing knitted flat patches [48, 60].
Manufacturing techniques may also have to be adapted to
match the demands of scaffold-fabrication. The trend
towards multi-material ‘‘hybrid’’ scaffolds with macro- and
nano-scaled elements which most closely mimic the host
tissue niche [12, 62] demands flexible manufacturing
methods which allow the combination of the fibrous
architecture with other materials (e.g. nano-fibers, hydro-
gels). A manufacturing technique by which fibrous scaf-
folds are fabricated similar to AM techniques was
developed by Hild et al. [47]. Another feature which
may be addressed with the help of textile manufactur
ing methods is the incorporation of nanofibers into 3D
Fig. 2 Engineering process of fibrous architectures as templates for TE/in situ TE applications. Image source: a [46], b [47], c [48], d [49],
e [50], f [51], g courtesy of TU Dresden
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stable scaffolds [47, 63, 64]. Such a combination of micro-
and nano-scaled elements can be employed to make use of
the favorable properties of nanofibers in a mechanically
stable 3D spatial environment [26] and to create hierar-
chical porous structures which are important for scaffold
vascularization [65].
2.2 Biomaterial fiber development for use
in engineered fibrous scaffolds
Theoretically most materials can be processed into fibers
by different fiber formation techniques like melt- wet- or
dry-spinning [66, 67], electrospinning [68] including
nanofiber yarns [69, 70], bio-spinning [71], interfacial
complexation [72] and microfluidic techniques [73].
However, fibers which may be used in textile manufac-
turing processes must meet certain criteria, namely
mechanical strength, elasticity, fiber diameter, fiber length,
yarn count [45]. To this date, these criteria basically restrict
the fiber formation techniques which are suitable for sub-
sequent textile manufacturing methods to melt- wet- and
bio-spinning. Due to the above-mentioned reasons, scaf-
folds made by textile manufacturing techniques are in most
cases made of synthetic melt- or wet-spun polymers (e.g.
PLA, PGA, PLLA, PLGA, PCL) [74]. To make use of
other promising natural or nature-derived biomaterials for
the fabrication of stable 3D spatial fibrous scaffolds,
intensified fiber development research is necessary. Con-
ventional fiber spinning techniques like wet or melt spin-
ning may generally be used for biomaterial fiber
fabrication. However, they often come along with harsh
processing conditions (high temperatures, strong/toxic
solvents), which could lead to denaturation of the bioma-
terial during fiber formation or to the presence of toxic
substances in the fabricated fibers. For the production of
biomaterial fibers, novel approaches have to be followed
[75] and existing spinning techniques have to be adapted in
order to preserve the microstructure of the biomaterials (i.e.
benign solvents, moderate process temperatures). In this
section, studies that aim at processing promising bioma-
terials (collagen, chitosan, regenerated silk, recombinant
proteins) into fibers suitable for textile manufacturing
techniques are presented (Fig. 3). Detailed descriptions of
the respective biomaterial properties can be found else-
where [76–79].
2.2.1 Collagen fibers
Collagen, the major component of native ECM, befits an
outstanding role in TE and in situ TE. The beneficial
properties of collagen (as explained elsewhere [76]) have
been exploited in numerous studies in all sub-branches of
TE [81, 82]. Since the first study on reconstituted collagen
fibers by extrusion from acidified collagen gels different
routes have been followed in order to develop aligned
fibers which possess sufficient mechanical strength for their
intended use and replicate the micro and nano-structural
composition of native collagen [83]. In recent years, sig-
nificant progress towards these goals has been made using
extrusion and electrochemical alignment techniques,
respectively.
Wet-spinning of collagen fibers can be realized by
extruding acidified collagen gels into a pH-neutral buffer,
where in vitro fibrillogenesis takes place [84]. Based on
this approach, research has been conducted in order to
improve the mechanical strength [85], increase production
rates [86], adjust the fiber properties by using different co-
agents, solution concentrations and collagen sources [87–
89] and examine fiber crosslinking [90]. Fiber-diameters of
10–2000 lm can be realized [83]. Although D-banded
collagen fibers can be verified [91], it remains unclear
whether native-type collagen without substantial propor-
tions of gelatin (denaturalized collagen) can be produced
by extruding acidified collagen [83]. Furthermore, the
usage of polyethylene glycol (PEG) in the fiber formation
buffer increases the wet fiber strength but results in non-
pure collagen fibers [92]. In addition, extruded collagen-
fibers are mechanically weak. Crosslinking may elevate the
ultimate strength of to an adequate level (10.5 MPa), but at
the same time negatively influences the cell-seeding
properties [93–96]. Another challenge lies in the fabrica-
tion of multi-filament yarns. While most studies describe
the fabrication of single fibers, there is little and unsatis-
fying work on the production of multi-filament collagen
yarns that may be used for textile manufacturing [97]. The
limitations described above render extruded collagen fibers
impractical for textile manufacturing methods.
By describing an electrochemical alignment technique,
Akkus et al. published pioneer work on engineered colla-
gen fibers. The principle of axial alignment of dialyzed
collagen along the isoelectric point and subsequent fibril-
logenesis in phosphate buffered saline (PBS) at 37 C and
genipin crosslinking was first described by Cheng et al.
[75]. By adjusting the genipin-crosslinking protocol, the
mechanical strength of the electronically aligned collagen
(ELAC) could be elevated to 109 MPa, which is in the
range of native tendon [98]. Younesi et al. developed a
rotating electrode device for the continuous fabrication of
ELAC fibers (Fig. 3a–e) [80]. However, the production
speed remains unclear. They twisted three single fibers
(ultimate tensile strength 20–50 MPa, 0.1–0.15 mm fiber
diameter) to a collagen thread (ultimate tensile strength
65 MPa) and used a hand weaving technique to produce a
3D bio-textile made of pure collagen fibers. hMSC’s pro-
liferated and distributed throughout the highly porous
scaffold underwent tenogenic differentiation even though
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no growth factors were added [80]. However, the authors
state that thinner filaments could be beneficial for cell
alignment. Thinner filaments would be also useful for
textile fabrication processes. If in vivo examinations of this
novel collagen-fiber material prove successful, electro-
chemical alignment could be a breakthrough technique for
the fabrication of pure collagen fibers.
Besides the promising developments in collagen fiber
development, there are some unsolved problems. For
example, there is a controversy about the correct cross-
linking procedure or whether collagen should be cross-
linked at all [99]. Furthermore, current studies describe
collagen fiber production on the laboratory scale in which
single fibers or fiber bundles comprising up to six fibers are
produced [94]. From the materials’ engineering point of
view, the next steps should include up-scaling of the fiber
fabrication process with the goal to produce multifilament
yarns and processing the collagen yarns on textile
machinery. Another critical issue remains the verification
of the ultrastructural features of collagen in fibers labeled
as ‘‘collagen fiber’’. There are studies on ‘‘collagen’’ fiber
scaffolds that lack the verification of collagen and in which
the source of the collagen fibers remains unclear [100,
101].
2.2.2 Chitosan fibers
Due to its favorable properties (e.g. abundant availability,
osteoactivity, promotes wound healing, anti-bacterial
effects) Chitosan (CS), a partially deacetylated derivative
of Chitin, has been widely used in applications for regen-
erative medicine [102, 103]. Chitosan fibers may be pro-
duced by electrospinning [104], microfluidic spinning
[105] or wet spinning techniques [51, 106–108].
Li and colleagues reported the fabrication of CS fibers
from glycine chloride ([Gly]Cl) ionic liquid spinning
dopes. 5–7 wt%. CS dissolved in in 4 wt% aqueous acetic
or [Gly]Cl solutions was spun with a spinneret (20 holes,
80 lm Ø). The filaments were coagulated in a dilute
Na2SO4/C2H5OH bath. Adequate mechanical properties
(maximum breaking tenacity: 3.77cN/dtex, maximum ini-
tial modulus: 2.3 cN/dtex) were registered [109]. Yan an
co-workers used chitin nanocrystal (ChiNC) as nanofiller to
reinforce CS fibers spun according to 109, leading to
increased mechanical properties [110]. Chitosan micro-
fibers reinforced by chitin nanofibrils were studied by
Yudin et al. [111]. The incorporation of 0.1–0.3 wt% of
chitin nanofibrils into chitosan matrix led to an increase in
strength and Young modulus.
Fig. 3 Examples for biomedical fiber development. Schematic of
device for the fabrication of endless collagen filament by electro-
chemical alignment (a), electrochemically aligned collagen (ELAC)
fibers (b), twisted thread (c) and pin-woven scaffold made of ELAC
fibers (d, e); Chitosan fibers (f), non-woven (g), knitted (h) and woven
(i). a–e from Ref. [80], f–i from [51]
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Toskas and colleagues successfully developed an
industrial-scale process to generate pure chitosan multi-
fibers (Fig. 3f–i) [51]. They dissolved up to 8.5 wt%. CS in
aqueous acetic solutions. The CS solution was pressed
through a spinneret (150–600 holes, 20–120 lm Ø) and led
through a coagulation bath composed of NaOH/EtOH. The
fiber diameter could be adjusted from 20.7 to 36.0 lm.
Tensile strength of 15.9 cN/tex was achieved. Woven and
knitted fabrics with adequate mechanical properties could
be manufactured [51]. Textile scaffolds made of these CS
fibers were tested in vitro, yielding promising results for
further use in TE applications [47, 112]. Chitosan-based
hyaluronic acid fibers were developed by Yamane et al
[113]. They used spinning dopes of 3.5 % CS in 2 %
aqueous acetic solutions, a spinneret with 50 holes and
0.1 mm Ø and a calcium coagulant bath. Hyaluronic acid
(HA) was added in an aqueous methanol solution coagu-
lation bath. CS-HA fibers showed higher tensile strengths
(168.2 ± 7.0 N/mm2) than CS only fibers (87.4 ± 2.0 N/
mm2) [113]. This fiber-type was used for the fabrication of
3D woven scaffolds [114]. Implantation into cartilage
defects in rabbits led to regeneration of hyaline-like carti-
lage [108, 115].
Similar to collagen fibers, the successful works on chi-
tosan fiber development call for intensified studies about
their in vivo behavior in order to utilizing fibrous chitosan
structures as scaffolds for TE and in situ TE applications.
2.2.3 Regenerated silk fibers
Silk fibroin-based scaffolds have been used in various TE
and in situ TE applications [116]. Although silk fibers
directly harvested from the spinning gland of spiders
(Ampullate/Dragline fibroins) or silkworms (Bombyx
mori) provide excellent properties (e.g. mechanical stabil-
ity, beneficial cellular reactions, biodegradability) they also
have shortcomings in terms of material inhomogeneity,
varying material properties and the low availability of
spider silk [79, 117]. To elude these problems which come
along with the use of biospun fibers, extensive research has
been put on the development of wet-spinning techniques
for regenerated silk fibers.
The fabrication of regenerated silk fibroin (RSF) fibers
is a challenging subject. Critical factors are the molecular
weight and concentration of silk fibroin [118], the solvent
system [119, 120], the solidification rate of the spinning
dope [121], the post-drawing ration [122] and the preser-
vation of flexibility in the dry state [123]. Conductive RSF
may be developed by the incorporation of multiwalled
carbon nanotubes (MWNTs) [124]. Their biocompatibility
may be improved by adding calcium chloride to the spin-
ning solution [125]. Due to the limited availability from
natural sources, recombinant production is especially
attractive for spider silk proteins [117]. Synthetic recom-
binantMajor Ampullate spider silk fibers were produced by
self-assembly [126–128] or wet-spinning [129–131]. There
are studies about the recombinant production and subse-
quent fiber-spinning of other proteins than silk fibroins, e.g.
silk-elastin like proteins [132], Amyloid Protein [133],
honeybee silk [134] or Keratin [135]. Those materials
could be used to create novel fibers with favorable prop-
erties for their use in regenerative medicine. However,
these attempts had limited success regarding the mechan-
ical properties of the fibers.
2.3 Fiber and scaffold functionalization
for the incorporation of stem cell homing factors
Fiber science provides useful techniques for the incorpo-
ration of functional substances into scaffolds. Much
research has been conducted on drug-loading and release of
fibers [136–138] and fiber based scaffolds [139]. The use of
hollow fibers with interconnected micro-pores through the
fiber wall has been studied for TE applications [140]. Fiber
surfaces can be functionalized with a diversity of nano- and
micro-particles in order to improve certain scaffold prop-
erties [141, 142]. The available techniques for fiber func-
tionalization and drug-release could also be used for the
incorporation and sustained release of biological cues such
as stem cell homing factors into fibrous architectures. The
possible mechanisms for the loading of fibers with bio-
logical cues are discussed in detail elsewhere [62].
Despite the manifold possibilities to functionalize fibers,
the only aqueous coatings [143–145] and gels [48, 63, 146]
have been used for the incorporation of biological cues into
textile scaffolds. Effective stem-cell recruitment by coating
a technique was achieved by Erggelet et al. [144]. They
prepared cell-free scaffolds by cutting commercially
available non-wovens of polyglycolic acid (PGA) into the
desired shape and soaking them with hyaluronic acid.
Directly prior to implantation into full-thickness articulate
cartilage defects of merino sheep, the scaffolds were
soaked in autologous sheep serum which served as chemo-
attractant. Three months after implantation, the formation
of a cell-rich repair tissue of cartilaginous appearance was
observed. The authors conclude that the scaffold allows the
in situ recruitment of mesenchymal stem cells (MSCs) by
serum as a chemo-attractant and subsequent guidance of
the progenitor cells towards formation of cartilage repair
tissue [144]. A similar scaffold system (PGA non-woven
soaked with hyaluronic acid and allogenic serum) was used
for the regeneration of the intervertebral disc in rabbits
[145]. In another study, coating of knitted polyester vas-
cular grafts with fibronectin (FN) and the stem cell homing
factor SDF-1 alpha led to positive results [143]. As these
findings suggest, coating is a rather simple technique that
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can easily be used directly prior to implantation, but it
comes along with the limitation that the biological cue is
only present on the fiber-surface, which impedes time-de-
pendent release kinematics.
Hydrogels may be used for local release of biological
cues. For the regeneration of anterior cruciate ligament
(ACL) defects in rabbits, Kimura et al. incorporated brai-
ded poly-L-lactic acid (PLLA) scaffolds with a basic
fibroblast growth factor (bFGF) loaded hydrogel in the
region of bone and with a collagen wrapping in the joint
cavity [146]. The authors observed significant bone
regeneration around the scaffold in the bone tunnel, which
could have been supported by enhanced cell migration due
to local bFGF release (Fig. 4b) [146]. Shen and co-workers
developed a bioactive scaffold made of knitted silk and a
collagen sponge with incorporated cell homing factor SDF-
1 alpha [48]. This scaffold for Achilles tendon regeneration
led to a reduction of inflammatory cells, SDF-1 alpha
caused increased selective recruitment of fibroblast-like
cells. Four weeks post-surgery, enhanced local endogenous
SDF-1 alpha and extracellular matrix (ECM) production
was registered [48].
The described findings show that the incorporation of
biological cues into textile scaffolds for in situ TE can lead
to favorable outcomes. With the help of available fiber
functionalization techniques, a broader range of substances
could be incorporated and programmable release kinetics
of biological cues from degradable fibers could be realized.
3 Textile cell-free scaffolds used for in situ tissue
engineering
This section gives an overview on recent studies in which
fibrous scaffolds are used for in situ TE applications. A
focus is put on the textile substrates and their incorporation
into the scaffold system. Only the most important features
of the different manufacturing techniques are discussed in
order to point out their benefits for their use as cell-free
scaffolds.
3.1 Knitted scaffolds
With knitting technology, three-dimensionally net-shaped
geometries are easily realizable [148–150]. Due to their
highly ordered loop-structure [151], knitted fabrics are
generally more elastic than woven or braided structures.
Using different knitting techniques and patterns (e.g. jer-
sey, interlock), the mechanical [152] and porous [153]
properties of knitted scaffolds may be tailored to suit the
specific demands of most sub-areas of regenerative medi-
cine [37]. This section describes successful studies using
knitted cell-free scaffolds, undermining the versatility and
suitability of knitting technology for the fabrication of cell-
free scaffolds.
A scaffold design based on the requirements of the
target cell niche, by logically combining different manu-
facturing techniques and materials, was realized by
Fig. 4 a Engineering process of multimodal nerve conduit based on a
tubular knit coated with electrospun nanofibers and incorporated with
aligned guidance fibers [63]. b Scaffold design based on the
requirements of different implantation sites: Hydrogels incorporating
bFGF localized to the bone tunnels, collagen wrapping in the joint
cavity [146]. c Hybrid vascular scaffold made of wet-spun microfibers
and electrospun nanofibers; manufacturing scheme, photographs and
SEM images of scaffolds [64, 147]
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Quigley et al. [63]. They knitted a sheath from PLA
monofilaments (90–100 lm Ø) which was coated with
electrospun PLA nanofibers to obtain controlled pore sizes
favorable for nerve conduits\2 lm [154]. This sheath was
filled with two types of aligned (PLGA) guidance fibers
(30–40 lm Ø) which are supported by an alginate hydrogel
impregnated with neurotrophic factors (NT-3 or BDNF
with LIF, SMDF and MGF-1) to provide neuroprotection,
stimulation of axonal growth and Schwann cell migration
(Fig. 4a). After implantation into 12 mm sciatic nerve
defect in rats for 4 weeks, patent regenerated nerves were
observed, in which axons grew through and beyond the
conduit. It was found that the aligned PLGA fibers support
guided Schwann cell migration and neuron outgrowth [63].
This study shows that intelligent scaffold design that
combines different manufacturing techniques, together
with the incorporation of biological factors, can lead to
favorable results. However, with the availability of more
appropriate (biomaterial) fibers, the outcomes could be
further improved.
The elastic structure of knits is useful where structures
that have to adapt to size changes are required. Matsumara
et al. implanted scaffolds made of PGA knitted fibers ? L-
lactide/e-caprolactone (PCL) copolymer sponge with outer
PGA and PCL copolymer monofilament reinforcement into
the inferior vena cava/left pulmonary artery of beagle dogs
for potential application in pediatric cardiovascular surgery
[155]. The initial strength of 9.3 N per 1 cm width was lost
by 1 month; the scaffold was degraded by hydrolysis
within 6 months, being replaced by native tissue. The
scaffolds adapted their shapes after implantation, which is
an important feature for its targeted use in pediatric surgery
[155, 156]. The authors also point out the cost-effective
and time-saving procedure compared to a cell-based
approach using the same biodegradable scaffold system
which was already tested in clinical trials [157, 158].
However, the scaffold design was not optimized for the
proliferation of vascular smooth muscle cells.
Mechanical stability and elasticity are among the most
important scaffold-features for skin regeneration [54]. The
use of fibrous structures enables the promotion of angio-
genesis by mechanical stimulation in vivo [159]. In a cell-
free approach, a warp knitted PLGA multifiber mesh
(PLGAm) (25 filaments/yarn; 15 lm filament Ø) was used
to improve the mechanical stability of porous collagen-
chitosan sponges (CCS) [49]. Wet-state tensile strengths of
2.79 MPa could be achieved [159]. After implantation in
full-thickness skin defects of rats, the PLGAm/CCS scaf-
folds inhibited wound contraction, effectively promoted
cell infiltration, neotissue formation and blood vessel
ingrowth. 8 weeks post-surgery, the tensile strength of the
repaired skin reached up to 73 % of normal skin [49].
3.2 Woven scaffolds
Compared to knits, woven fabrics may be designed to
achieve higher tensile strength and less elasticity. Besides
flat ‘‘2D’’ fabrics, 3D weaving technology allows for the
generation of defined spatial geometries [160], which are
widely used in fiber reinforced composite applications [33]
and also in TE applications [39, 161–163]. With 3D
weaving, the through-plane strength of woven fabrics can
be improved considerably [32].
Most of the times, weaving techniques are used when
high mechanical properties are required. Therefore, popu-
lar fields of applications are vascular grafts [147, 164],
tendon regeneration [165] or hernia repair [59].
Yokota an colleagues designed the mechanical proper-
ties of a small-caliber vascular graft (4 mm Ø) made of a
type I bovine collagen microsponge compound with a
cylindrically woven biodegradable and absorbable polymer
tube (airspun core (PLA)-sheath (PGA) compound yarn),
so that initial tensile modulus and tensile strength of the
woven grafts (tensile strength: *30 MPa, modulus:
*200 MPa) were much higher than of native carotid
arteries (tensile strength: *8 MPa, modulus: *60 MPa)
[164]. With absorption of the PGA fibers, tensile strength
and modulus decreased to a level that was almost equiva-
lent to that of the native carotid artery of mongrel dogs. An
endothelial cell monolayer, smooth muscle cells and a
reconstructed vessel wall with elastin and collagen fibers
could be observed 12 months post-surgery [147, 164]. In
another study concentrating on the mechanical properties,
Derwin et al. used a commercially available woven PLA
sheet (X-Repair) for the augmentation of rotator cuff
defects in dogs [166]. They observed that directly after
implantation the repair augmentation significantly
increased the ultimate load by 23 % compared to un-aug-
mented repair, while the stiffness remained unaltered. At
12 weeks, the PLA scaffold augmented repairs demon-
strated significantly less tendon retraction and significantly
greater cross-sectional area (137 %), stiffness (26 %), and
ultimate load (35 %) than did repairs that had not been
augmented [166]. The same material was also positively
evaluated in an initial-load test of augmented human
cadaver rotator cuffs [167].
Inui and co-workers studied different surface qualities of
a cell free scaffold in a rabbit rotator cuff defect model
[165]. They fabricated a woven fabric made of PLLA fibers
with a smooth surface on the outside and a rough (pile-
finished) surface on the inside [168]. The scaffolds were
implanted into defects of the infraspinatus tendon. The
rough surface allowed better cell migration while the
smooth surface prevented cell attachment. No significant
difference in ultimate failure load between scaffolds and
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the control group (reattached natural infraspinatus tendons)
could be observed. 8 weeks post-surgery, the failure
strength of intact infraspinatus tendons was regained [165].
This study shows that adjusting surface structures on the
macroscopic level may be used to control cell adhesion and
migration. The versatility of weaving technology to create
3D structures and fabrics with defined porous properties
remain largely unexploited in studies using woven cell free
scaffolds.
A cell-free scaffold system made of hand-woven meshes
from native dragline silk of the spider Nephila spp. for
appliance in hernia repair was developed by Schaefer-
Nolte et al. [59]. To investigate their usage as fascia
replacement material, the meshes and two compare groups
(commercially available hernia meshes Ultrapro and Sur-
gisis) were tied onto the paravertebral fascia of rats. The
relative elongation of the spider-silk meshes was higher
than the relative elongation of Ultrapro and Surgisis,
demonstrating the spider-silks’ superior adaptability to
changing body shapes. Rapid cell migration into the spider
silk meshes and milder immune responses than in the
compare croup were registered. Complete degradation was
observed after 4 months. However, the authors point out
that the functionality of spider silk meshes has to be vali-
dated in real hernia models [59]. This study points out the
usefulness of novel biomaterial fiber materials. At the same
time, it becomes obvious that intensified research is nec-
essary before such materials can be processed with textile
manufacturing methods.
3.3 Braided scaffolds
Braiding generally leads to rope-like structures, either
dense, hollow, or with embedded core fibers. More com-
plex braiding techniques allow for the fabrication of 3D
net-shaped structures [169]. Due to the fiber orientation in a
specific angle to the braiding direction and the resulting
mechanical properties of braided structures, braiding is
among the most common scaffold fabrication techniques
used in ligament TE [170].
Aurora et al. investigated PLLA/PGA braid reinforce-
ment as a method for engineering the mechanical proper-
ties of lyophilized human fascia patches [171]. The authors
conclude that the patch reinforcement may be sufficient to
provide mechanical augmentation to rotator cuff repairs
and minimize tendon retraction [171]. The same scaffold
model (PLLA braid reinforced fascia) was used for rotator
cuff repair in dogs [172]. While at time zero the ultimate
load of the augmented repairs was 46 ± 25 % more than
non-augmented repairs. However, the ultimate load did not
increase with time [172]. Hence, the mechanical strength
lost by scaffold degradation could not be compensated for
by regenerated tissue. In another study, Cooper et al. used
multifilament PLLA fibers fabricated into 3D square braids
for ACL regeneration in rabbits [173]. Scaffolds seeded
with ACL cells were compared to cell-free scaffolds. The
initial tensile properties of the braided scaffolds were
similar to that of native tissue. Poor tissue ingrowth was
observed 4 weeks post-surgery. After 12 weeks, only the
cell-seeded scaffolds showed excellent tissue infiltration
and revascularization. The cell-seeded scaffolds also
retained more of their tensile strength than the cell-free
scaffolds [173].
The problems identified in the above-described studies
may occur since the scaffolds were not consequently
designed based on the requirements of the host tissue. The
sole use of cell-free scaffolds without the incorporation of
biological cues seems insufficient for ligament regeneration.
In the subject of nerve regeneration thorough research has
been conducted on braided, collagen coated PGA tubes with
incorporated collagen sponges or fibers. This scaffold type
was successfully applied for the regeneration of various dif-
ferent types of nerves in animal models [174–178] prior to its
use in clinical studies [179–181] (see ‘‘Clinical Studies’’). The
same workgroup also developed a nerve guide tube based on
the well-established PGA-collagen scaffold for the repair of
long nerve defects [50]. They used braided scaffolds of PLLA
monofilaments and PGA multifilament yarns (1:1) with a
collagen coating for the repair of long nerve defects in beagle
dogs. Compared to scaffolds consisting of PGA-collagen
only, the PLLA-PGA-collagen scaffolds led to faster func-
tional recovery. The lumen structure which is necessary for
nerve regeneration was maintained for 12 months. The
tubular scaffolds also allowed for the development of normal
tibialis anterior (TA) muscle cells [50].
3.4 Non-woven scaffolds
Since their pore size is accurately adjustable, non-woven
fabrics are commonly used for filtration applications [35].
This beneficial property has also been exploited in TE
applications, especially for cartilage engineering [182–185]
and biomaterial evaluation [186–189]. As well as in clas-
sical TE approaches, along with the use of collagen-ma-
trixes [190–192], non-woven fabrics are desirable materials
for in situ cartilage regeneration.
Yokoya and co-workers developed a cell-free tendon-
bone insertion made of a PGA nonwoven sheet for the
repair of full-thickness rotator cuff defects in rabbits [193].
Compared to a PCL scaffold used in a control group, the
defect sites showed a well-arranged fibrocartilage layer,
mainly regenerated by type III collagen. Mechanical
examinations revealed significantly higher values in tensile
strength [2.36 MPa (PGA) vs. 1.80 MPa (PCL) after
16 weeks] and Young’s modulus [5.53 MPa (PGA) vs.
3.74 MPa (PCL) after 16 weeks] [193]. Another scaffold
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system for rotator cuff regeneration consists of sheets of
non-woven chitin fibers implanted into defects of the
infraspinatus tendon [194]. Compared to untreated defects,
the scaffolds increased cell numbers and improved colla-
gen fiber alignment. However, the scaffolds possessed
inadequate mechanical strength [194]. With a molding
technique, Yang et al. fabricated non-woven nerve-guid-
ance conduits made of bombyx mori silk fibroin oriented
fibers cast in fibroin solution [195]. The grafts were used to
bridge a 10 mm gap in sciatic nerves in rats. The scaffolds
showed favorable maximum fracture strength (5.5 MPa)
and compressive strength (2.5 MPa) in the wet state. They
could promote peripheral nerve regeneration. The authors
suggest that introducing neurothropic factors could further
improve the scaffold, thus becoming a real alternative for
nerve autografts [195]. From the described studies, it
becomes clear that researchers do not make adequate use of
the possibility to adjust the porous properties of non-wo-
vens. Designing the nonwovens based upon the relations of
porosity and cell-material interaction should be considered
in order to exploit the benefits given by non-wovens.
Zhu and colleagues pursued a design-approach for vas-
cular grafts which allows vascular smooth muscle cells
(VSMCs) infiltration and their circumferential alignment
(Fig. 4c) [64]. Therefore, they fabricated a bi-layered
scaffolds composed of wet-spun circular aligned PCL-
fibers covered with an electrospun PCL coating. They
obtained vascular grafts with mechanical properties similar
to native arteries of rats. The scaffold design plays a key
role for the successful cellular integration: The large
interconnected pores enabled the VSMCs to infiltrate the
graft wall and the circumferentially aligned fibers served as
topographical guidance [64].
3.5 Clinical studies using cell-free fiber based
scaffolds
Similar to in vitro TE, there are comparatively few in situ TE
approacheswhich have been evaluated in clinical studies. The
demand on in situ TE as an approach that avoids the major
disadvantages of classical in vitro TE and thus may be trans-
ferred to clinical application in a more straight forward way
needs to be manifested in clinical case studies. Especially for
nerve regeneration, cell-free fiber based scaffolds were suc-
cessfully used in clinical case studies. The easy fabrication of
tubes by textile manufacturing techniques and their possible
off-the-shelve availability support their use as a cost-effective
treatment of nerve defects. Vascular TE also benefits from
fibrous tubes; however there are few clinical studies on in situ
vascularTE [9]. This section describes promising clinical case
studies using cell-free fiber based scaffolds.
Remarkable clinical application studies in the field of
nerve regeneration were conducted by Inada et al. [181].
They developed a braided, collagen coated PGA tube filled
with a collagen sponge (70–80 % collagen type I, 20–30 %
collagen type III) for the regeneration of large peripheral
motor/sensory nerve defects and for causalgia-treatment,
respectively. The grafts had a PGA wall thickness of 50 lm
and tube-diameters of 4 mm and were used to bridge nerve
gaps of up to 65 mm in length [174]. After implantation, the
patients experienced functional recovery of their finger/foot
[179], regained the voluntary ability to lift their eyebrow
[181] and regained full use of their fingers after causalgia and
allodynia had disappeared [180]. The authors conclude that
their PGA/collagen scaffold is a promising option and viable
alternative for conventional nerve grafts. In another clinical
study on nerve-repair, Aberg and co-workers used non-wo-
vens made of resorbable poly[(R)-3-hydroxybutyrate]
(PHB) fibers for the treatment of complete median and/or
ulnar nerve injuries at the wrist/forearm level by wrapping
the PHB non-woven pads around the nerve ends in a tube-
like fashion [196]. Compared to standard end-to-end sutur-
ing, the treatment with PHB non-wovens may be advanta-
geous regarding sensory recovery and manual muscle tests.
The authors point out, that the wrap-around technique also
offers practical advantages to the surgeon [196]. Currently,
with the NeurotubeTM conduit (Synovis Life Technologies,
St. Paul, USA) there is one commercially available and FDA
approved nerve graft made of woven PGA fibers [197–199].
Fibrous cell-free scaffolds for in situ reconstruction of
small joints were tested in clinical studies by Honkanen,
Tiihonen et al. The scaffold system made of knitted (P(L/
D)LA) fibers which was investigated by Waris et al. in a
pig model [200] was used for the reconstruction of
metacarpophalangeal joints in rheumatoid arthritis patients
[201–203]. The knitted interposition scaffold was com-
pared to Swanson silicone implants. After 2 years the
improvement in clinical assessments was comparable in
both groups, except for better maintenance of palmar
alignment in the Swanson group. The lack of implant
fractures and intramedullary osteolysis were advantages of
the knitted implant [202]. After a mean follow-up of seven
years, satisfactory pain relief was registered, but the
function was limited. The patient satisfaction was similar
in the silicone implant group and in the knitted implant
group. The authors conclude that the main clinically rele-
vant outcomes are similar and that due to soft tissue defi-
ciencies long-term function and alignment problems cannot
be resolved with PLDLA interposition implant [203]. In
reconstruction of the destructed trapeziometacarpal joint in
arthritic patients the P(L/D)LA) knitted scaffold was
compared to tendon interposition [204]. The authors con-
clude that bioreplaceable interposition arthroplasty using
the knitted scaffold works at least as well as tendon
interposition and that the operation using the knitted scaf-
fold is easier [204]
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4 Conclusion
In this review, the preconditions and possibilities of textile
manufacturing methods, fiber development and functional-
ization for the fabrication of cell-free scaffolds for in situ TE
have been summarized. Studies in this field encompass a
variety of engineered scaffolds from simple grafts [193] to
complex multi-material scaffolds [63]. The basic benefits of
fibrous scaffold architectures, namely mechanical stability,
porosity and degradability, are employed in most cases.
However, fibrous engineered scaffold systems stay behind
the possibilities which are principally offered by textile
manufacturing techniques and their combination with other
manufacturing techniques. In order to make use of the whole
range of favors, there are four main issues which need to be
addressed: (1) Logical combination of manufacturing tech-
niques and materials. (2) Biomaterial fiber development. (3)
Adaption of textilemanufacturing techniques to the demands
of scaffolds for regenerative medicine. (4) Incorporation of
biological cues (e.g. stem cell homing factors).
(1) A crucial premise for successful scaffold develop-
ment is that the choice of material, manufacturing
techniques and biological cues must be dictated by
the targeted repair-tissue. The paradox of expert
knowledge in specific techniques on the one hand
and a broad overview about the huge variety of
existing materials and techniques on the other hand
may only be solved if intense interdisciplinary
collaboration is consequently pursued. The combi-
nation of appropriate materials, manufacturing and
functionalization techniques must be derived from
the desired scaffold-properties [62].
(2) Besides the well-established synthetic polymers (e.g.
PLA, PGA, PLGA, PBT), recent developments in
biomaterial fiber engineering enable the exploitation
of the favorable material properties from materials
such as collagen, chitosan, regenerated silk or
recombinant proteins in fibers suitable for their
processing into stable spatial scaffolds [51, 80, 116,
117]. However, intensified studies concerning fiber
properties and the in vitro and in vivo behavior of
those newly developed fibers have to be conducted
in order to use them for regenerative medicine.
Furthermore, regulatory restrictions regarding the
use of novel fibrous materials in the human body
must be taken into account [12].
(3) The possibilities offered by textile manufacturing
techniques to create structures with adjusted
mechanical and porous properties may only be
exploited if the manufacturing method is chosen
based on the demands of the targeted tissue [30].
Manufacturing methods have to be adapted in order
to allow the combination of the fibrous architecture
with other materials (e.g. nano-fibers, hydrogels),
thus creating structurally hierarchical ‘‘hybrid’’
scaffolds which match the host tissue. Also, tech-
niques by which 3D net shaped geometries (similar
to AM techniques) may be fabricated from fibers are
to be further developed [47], thus allowing simple
fabrication of custom-shaped and patient specific
fibrous scaffolds.
(4) Especially for in situ TE, the incorporation and sustained
release of biological cues into scaffolds is crucial for
their successful application [2, 7]. Despite this fact, the
incorporation of biological cues is not looked at in most
cases when fiber-based cell-free scaffolds are used for
in situ TE. A functioning fiber-based release-system for
the sustained delivery of biological cues could help in
achieving an important goal in guiding host cells to form
a well-integrated functional structure [2]. Therefore,
intensified research is necessary.
Depending on the type of engineered tissue and the
application, clinical studies showed that cell-free fibrous
scaffolds may be superior to or as well as conventional
‘‘gold standard’’ treatments [181, 196, 202]. Besides the
obvious advantages of in situ TE (off-the-shelve scaffold
availability, less cost and time consumption) it has to be
considered that in terms of tissue ingrowth, tissue forma-
tion and regained functionality of regenerated tissue, cell-
free fibrous scaffold systems do not always yield better
results as their cell-seeded counterparts [173]. With the
availability of novel biomaterial fibers with sufficient
mechanical performance for textile manufacturing tech-
niques and the appropriate addition and sustained release of
cell homing factors and growth factors, in situ TE
approaches using cell-free fibrous scaffolds could be ele-
vated to various clinical applications. To make progress
towards this goal, the interdisciplinary collaboration of
experts in the fields of medicine, biomaterials science and
textile engineering has to be consequently pursued.
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